Stay updated on Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new entry '2018 ( U.S. NIH Grant/Contract )' was added under the Other Study ID Numbers section, signaling an NIH-related identifier for the study.
    Difference
    0.0%
    Check dated 2026-08-25T20:44:20.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5 in the footer, indicating a minor version update to the site's template/CMS.
    Difference
    0.0%
    Check dated 2026-08-11T19:47:16.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.3 to v3.6.4, signaling a small software/documentation update applied to the page. This change does not alter the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-21T12:46:24.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.3, indicating a page update rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-30T01:56:16.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page now indicates recruitment has ended and adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment heading and updates the revision tag from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T19:09:08.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5, representing a minor update to how the study record is presented.
    Difference
    0.0%
    Check dated 2026-06-08T16:46:15.000Z thumbnail image

Stay in the know with updates to Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.